1-20 of 1907

Search Results for selective

Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Article

Selective Contracting for Hospital Care Based on Volume, Quality, and Price: Prospects, Problems, and Unanswered Questions

Available to Purchase
Mark S. Freeland, Sandra S. Hunt, Harold S. Luft
J Health Polit Policy Law (1987) 12 (3): 409–426.
DOI: https://doi.org/10.1215/03616878-12-3-409
Published: 01 June 1987
...Mark S. Freeland; Sandra S. Hunt; Harold S. Luft There is a burgeoning interest in selective contracting for specialized hospital services based on volume, price, and quality. The systematic exclusion or inclusion of particular institutions has been extolled by some as an arrangement to reduce...
View articletitled, <span class="search-highlight">Selective</span> Contracting for Hospital Care Based on Volume, Quality, and Price: Prospects, Problems, and Unanswered Questions View PDF for article titled, <span class="search-highlight">Selective</span> Contracting for Hospital Care Based on Volume, Quality, and Price: Prospects, Problems, and Unanswered Questions
Journal Article

Selective Pregnancy Reduction: Medical Attitudes, Legal Implications, and a Viable Alternative

Available to Purchase
Elizabeth Villiers Gemmette
J Health Polit Policy Law (1991) 16 (2): 383–395.
DOI: https://doi.org/10.1215/03616878-16-2-383
Published: 01 April 1991
...Elizabeth Villiers Gemmette “Selective pregnancy reduction” is a medical procedure used to reduce a multiple pregnancy, often a multiple pregnancy induced by in vitro fertilization or drug therapy. In such instances, healthy embryos are sacrificed in order to maximize the chances of survival...
View articletitled, <span class="search-highlight">Selective</span> Pregnancy Reduction: Medical Attitudes, Legal Implications, and a Viable Alternative View PDF for article titled, <span class="search-highlight">Selective</span> Pregnancy Reduction: Medical Attitudes, Legal Implications, and a Viable Alternative
Journal Article

The Resurgence of Selective Contracting Restrictions

Available to Purchase
Jill A. Marsteller, Randall R. Bovbjerg, Len M. Nichols, Diana K. Verrilli
J Health Polit Policy Law (1997) 22 (5): 1133–1189.
DOI: https://doi.org/10.1215/03616878-22-5-1133
Published: 01 October 1997
...Jill A. Marsteller; Randall R. Bovbjerg; Len M. Nichols; Diana K. Verrilli As managed care has spread, so has legislation to force plans to contract with any willing provider (AWP) and give patients freedom of choice (FOC). Managed care organizations’ selective networks and provider integration...
View articletitled, The Resurgence of <span class="search-highlight">Selective</span> Contracting Restrictions View PDF for article titled, The Resurgence of <span class="search-highlight">Selective</span> Contracting Restrictions
Journal Article

Health Plan Selection in the Federal Employees Health Benefits Program

Available to Purchase
James A. Schuttinga, Marilyn Falik, Bruce Steinwald
J Health Polit Policy Law (1985) 10 (1): 119–139.
DOI: https://doi.org/10.1215/03616878-10-1-119
Published: 01 February 1985
...), was used to study insurance plan selection when multiple fee-for-service options as well as HMOs are available. There is evidence of biased selection of health risks in the FEHBP, yet historically the program has exhibited considerable stability. The stability may be attributable partly to control over...
View articletitled, Health Plan <span class="search-highlight">Selection</span> in the Federal Employees Health Benefits Program View PDF for article titled, Health Plan <span class="search-highlight">Selection</span> in the Federal Employees Health Benefits Program
Journal Article

Patient Selection for Heart Transplantation: When Is a Discriminating Choice Discrimination?

Available to Purchase
Karen J. Merrikin, Thomas D. Overcast
J Health Polit Policy Law (1985) 10 (1): 7–32.
DOI: https://doi.org/10.1215/03616878-10-1-7
Published: 01 February 1985
...Karen J. Merrikin; Thomas D. Overcast Section 504 of the Rehabilitation Act of 1973 prohibits discrimination against the handicapped in any program receiving federal funds. With its implementing regulations, Section 504 may well apply to the selection of patients for medical treatments...
View articletitled, Patient <span class="search-highlight">Selection</span> for Heart Transplantation: When Is a Discriminating Choice Discrimination? View PDF for article titled, Patient <span class="search-highlight">Selection</span> for Heart Transplantation: When Is a Discriminating Choice Discrimination?
Journal Article

Choice by Constraint: The Selection and Function of Specialties among Women Physicians-in-Training

Available to Purchase
Lynne R. Davidson
J Health Polit Policy Law (1979) 4 (2): 200–220.
DOI: https://doi.org/10.1215/03616878-4-2-200
Published: 01 April 1979
...Lynne R. Davidson This paper asserts that the selection of medical specialty by women physicians-in-training is a “choice by constraint.” Comparative data on men and women interns and residents are provided in order to document parameters of constraint in three separate areas: 1) subjective reasons...
View articletitled, Choice by Constraint: The <span class="search-highlight">Selection</span> and Function of Specialties among Women Physicians-in-Training View PDF for article titled, Choice by Constraint: The <span class="search-highlight">Selection</span> and Function of Specialties among Women Physicians-in-Training
Journal Article

Adverse Consequences of Adverse Selection

Available to Purchase
Mark Pauly, Sean Nicholson
J Health Polit Policy Law (1999) 24 (5): 921–930.
DOI: https://doi.org/10.1215/03616878-24-5-921
Published: 01 October 1999
...Mark Pauly; Sean Nicholson Copyright © 1999 by Duke University Press 1999 References Jackson-Beeck , Marilyn , and Joel Kleinman. 1983 . Evidence for Self-Selection among Health Maintenance Organization Enrollees. Journal of the American Medical Association 250 ( November...
View articletitled, Adverse Consequences of Adverse <span class="search-highlight">Selection</span> View PDF for article titled, Adverse Consequences of Adverse <span class="search-highlight">Selection</span>
Journal Article

Red State, Blue State, Flu State: Media Self-Selection and Partisan Gaps in Swine Flu Vaccinations

Available to Purchase
Matthew A. Baum
J Health Polit Policy Law (2011) 36 (6): 1021–1059.
DOI: https://doi.org/10.1215/03616878-1460569
Published: 01 December 2011
... . USA Today/Gallup Poll . 2009 . Swine Flu (USAIPOUSA2009-TR0505) . May 5 . Red State, Blue State, Flu State: Media Self-­Selection and Partisan Gaps in Swine Flu Vaccinations...
View articletitled, Red State, Blue State, Flu State: Media Self-<span class="search-highlight">Selection</span> and Partisan Gaps in Swine Flu Vaccinations View PDF for article titled, Red State, Blue State, Flu State: Media Self-<span class="search-highlight">Selection</span> and Partisan Gaps in Swine Flu Vaccinations
Journal Article

Politics, Health, and Health Care: Selected Essays

Available to Purchase
William P. Brandon
J Health Polit Policy Law (2013) 38 (6): 1193–1199.
DOI: https://doi.org/10.1215/03616878-2373287
Published: 01 December 2013
...William P. Brandon Marmor Theodore R. and Klein Rudolf . Politics, Health, and Health Care: Selected Essays . New Haven and London : Yale University Press , 2012 . xv + 573 pp. $95.00 cloth. Copyright © 2013 by Duke University Press 2013 The British philosopher Michael...
View articletitled, Politics, Health, and Health Care: <span class="search-highlight">Selected</span> Essays View PDF for article titled, Politics, Health, and Health Care: <span class="search-highlight">Selected</span> Essays
Journal Article

Compensation for Medical Injury in New Zealand: Does “No-Fault” Increase the Level of Claims Making and Reduce Social and Clinical Selectivity?

Available to Purchase
Peter Davis, Roy Lay-Yee, Julie Fitzjohn, Phil Hider, Robin Briant ...
J Health Polit Policy Law (2002) 27 (5): 833–854.
DOI: https://doi.org/10.1215/03616878-27-5-833
Published: 01 October 2002
... the claims process was well targeted, thelevel of claims making and receipt was low, with the ratio of successful claims to potentially compensable events being approximately 1:30. Comparison of social and clinical characteristics of the two data sets revealed a degree of selectivity. Compared...
View articletitled, Compensation for Medical Injury in New Zealand: Does “No-Fault” Increase the Level of Claims Making and Reduce Social and Clinical <span class="search-highlight">Selectivity</span>? View PDF for article titled, Compensation for Medical Injury in New Zealand: Does “No-Fault” Increase the Level of Claims Making and Reduce Social and Clinical <span class="search-highlight">Selectivity</span>?
Image
Appendix Figure A1 Selection of initiatives for analysis.

Selection of initiatives for analysis.

Available to Purchase
in The Grassroots of Grass: Cannabis Legalization Ballot Initiative Campaign Contributions and Outcomes, 2004–2016 > Journal of Health Politics, Policy and Law
Published: 01 February 2020
Appendix Figure A1 Selection of initiatives for analysis. More
Image
Figure 1 Selection of the study sample.

Selection of the study sample.

Available to Purchase
in Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i Loophole > Journal of Health Politics, Policy and Law
Published: 01 December 2022
Figure 1 Selection of the study sample. More
Image
Figure 5 Antiabortion rulings by judge selection methods.

Antiabortion rulings by judge selection methods.

Available to Purchase
in State Courts, State Legislatures, and Setting Abortion Policy > Journal of Health Politics, Policy and Law
Published: 01 August 2023
Figure 5 Antiabortion rulings by judge selection methods. More
Image
Figure 2 Informational choice provided to the subjects in the selection condition of the experiment.

Informational choice provided to the subjects in the selection condition of...

Available to Purchase
in Public Preferences for New Information on Opioids > Journal of Health Politics, Policy and Law
Published: 01 April 2020
Figure 2 Informational choice provided to the subjects in the selection condition of the experiment. More
Image
Figure 3 Levels of funding selected by individuals at round 4, sorted by percentage selecting level 2 or 3.

Levels of funding selected by individuals at round 4, sorted by percentage ...

Available to Purchase
in How Would Low-Income Communities Prioritize Medicaid Spending? > Journal of Health Politics, Policy and Law
Published: 01 June 2020
Figure 3 Levels of funding selected by individuals at round 4, sorted by percentage selecting level 2 or 3. More
Image
Figure 1. Generics' Market Share (by Volume) in Selected Cases. / Source: Elaborated by author from data in Danzon and Furukawa (2011).

Generics' Market Share (by Volume) in Selected Cases Source : Elaborated ...

Available to Purchase
in The Politics and Policies of Regulating Generics in Latin America: A Survey of Seventeen States > Journal of Health Politics, Policy and Law
Published: 01 June 2017
Figure 1 Generics' Market Share (by Volume) in Selected Cases Source : Elaborated by author from data in Danzon and Furukawa ( 2011 ). More
Image
Figure 1 Percentage of deaths from noncommunicable diseases in selected African countries.

Percentage of deaths from noncommunicable diseases in selected African coun...

Available to Purchase
in Negotiating Change: Ideas, Institutions, and Political Actors in Tobacco Control Policy Making in Mauritius > Journal of Health Politics, Policy and Law
Published: 01 June 2021
Figure 1 Percentage of deaths from noncommunicable diseases in selected African countries. More
Image
Figure 2 Levels of funding selected by groups at round 3, sorted by percentage selecting level 2 or 3.

Levels of funding selected by groups at round 3, sorted by percentage selec...

Available to Purchase
in How Would Low-Income Communities Prioritize Medicaid Spending? > Journal of Health Politics, Policy and Law
Published: 01 June 2020
Figure 2 Levels of funding selected by groups at round 3, sorted by percentage selecting level 2 or 3. More
Image
Figure 2 Policy responses to COVID-19 in select Brazilian, Mexican, and US states. Note: Figure shows trends in mobility (shaded gray regions), COVID-19 cases (black lines), and policy (colored bars [online only]) for selected states in Brazil, Mexico, and the United States. The width of the colored bars corresponds to variation in the level of policy implementation: thick lines correspond to mandatory statewide orders,whereas lighter, thinner lines reflect periodswhen the policywas recommended but not required, required but partially implemented, or required but geographically limited

Policy responses to COVID-19 in select Brazilian, Mexican, and US states. ...

Available to Purchase
in Who Stays at Home? The Politics of Social Distancing in Brazil, Mexico, and the United States during the COVID-19 Pandemic > Journal of Health Politics, Policy and Law
Published: 01 December 2021
Figure 2 Policy responses to COVID-19 in select Brazilian, Mexican, and US states. Note : Figure shows trends in mobility (shaded gray regions), COVID-19 cases (black lines), and policy (colored bars [online only]) for selected states in Brazil, Mexico, and the United States. The width More
Image
Growth in rebates, list prices, and net prices in select categories (2009-2019). Panel A Insulins. Panel B Hepatitis C antivirals. Panel C Antidepressants. Panel D HIV antiretrovirals. Notes: ATC = anatomical therapeutical chemical classification by the World Health Organization Collaborating Centre on Drug Statistics Methodology. Insulins included are in ATC level 4 categories A10AB (fast acting), A10AC (intermediate acting), A10AD (fast acting with intermediate or long acting), or A10AE (long acting) and include 27 product formulations: afrezza (two formulations), apidra, basaglar, humalog/mix (eight formulations), humulin/mix (eight formulations), lantus (three formulations), soliqua, toujeo (two formulations), and xultophy. The HCV antivirals category (ATC4 category J05AP) includes 14 product formulations: daklinza (three formulations), epclusa, harvoni, mavyret, olysio, sovaldi, victrelis, viekira/xr, vosevi, and zepatier. Hepatitis C products shown starting in 2014 as a result of launch of Sovaldi in late 2013. The antiretroviral drugs are identified as the subset of ATC3 category J05A (direct-acting antivirals) that is approved for HIV and include 71 product formulations: atripla, biktarvy, combivir, complera, crixivan (three formulations), descovy, emtriva (two formulations), epivir (three formulations), epivir hbv (three formulations), epzicom, fuzeon, genvoya, intelence (two formulations), isentress (five formulations), juluca, kaletra (three formulations), lexiva (two formulations), norvir, odefsey, prezista (seven formulations), reyataz (six formulations), selzentry, stribild, sustiva (four formulations), symtuza, tivicay (three formulations), triumeq, trizivir, truvada (four formulations), viread (five formulations), and ziagen (two formulations). The antidepressants category (ATC3 category N06A) includes 58 product formulations: aplenzin (three formulations), celexa (three formulations), cymbalta (three formulations), fetzima (five formulations), lexapro (four formulations), pristiq (three formulations), sarafem (three formulations), savella (five formulations), trintellix (three formulations), viibryd (fivve formulations), wellbutrin sr (five formulations), wellbutrin xl (two formulations), and zoloft (four formulations).

Growth in rebates, list prices, and net prices in select categories (2009-2...

Available to Purchase
in The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies > Journal of Health Politics, Policy and Law
Published: 01 December 2022
Figure 2 Growth in rebates, list prices, and net prices in select categories (2009-2019). Panel A Insulins. Panel B Hepatitis C antivirals. Panel C Antidepressants. Panel D HIV antiretrovirals. Notes : ATC = anatomical therapeutical chemical classification by the World Health Organization More